Drug Profile
Research programme: anti-fungal therapeutics - Demuris
Alternative Names: DC066ALatest Information Update: 28 Aug 2020
Price :
$50
*
At a glance
- Originator Demuris
- Class
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Mycoses
Most Recent Events
- 28 Aug 2020 No recent reports of development identified for research development in Mycoses in United Kingdom
- 07 Jul 2016 Early research in Mycoses in United Kingdom (unspecified route)